ST Barbara Ltd (SBM)
Australian Securities Exchange · Australia · prices in AUD · close of 27 Oct 2026
Key indicators
| Last close | AUD 0.825 |
|---|---|
| 52-week range | 0.405 – 0.930 |
| Return, 1 month / 3 months | +0.6% / +88.2% |
| Return, 1 year / 3 years | +60.5% / +289.0% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 72.6% |
| Worst drawdown (1 year) | -52.3% |
| Average daily value traded | 9.54M AUD |
| Dividend yield | 6.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
St Barbara is an Australian gold producer that mines and processes gold ore at its operations in Western Australia. The company runs underground and open pit mines and produces gold doré and concentrate, which are refined into gold metal. Its customers are gold refiners and bullion markets. St Barbara is headquartered in Perth, Western Australia, and its operations are focused on gold extraction and processing rather than on other metals or services.
ST Barbara Ltd trades under the code SBM on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ST Barbara Ltd (SBM) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.825 on 27 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 165 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 60.5% and over the last three months it rose 88.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 93 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 31.7% | ||
| From 52-week high | -11.3% | ||
| Momentum | 94 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 88.2% | ||
| 6-month return | 32.6% | ||
| 12-month return, skipping the last month | 59.6% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 72.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -52.3% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 9.54M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 6.1% | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.6% |
|---|---|
| 1 month | +0.6% |
| 3 months | +88.2% |
| 6 months | +32.6% |
| 1 year | +60.5% |
| 3 years | +289.0% |
| 5 years | +38.7% |
Signals
| 50-day / 200-day average | 0.760 / 0.626 |
|---|---|
| Golden / death cross (60 days) | Golden, 25 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.045 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Sep 2026 | AUD 0.0500 |
| 8 Sep 2021 | AUD 0.0200 |
| 2 Mar 2021 | AUD 0.0400 |
| 7 Sep 2020 | AUD 0.0400 |
| 3 Mar 2020 | AUD 0.0400 |
| 3 Sep 2019 | AUD 0.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.